IMA Q1 2024 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$67M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

-$10M

Operating Income

-$18M

Net Income

-$16M

EPS (Diluted)

$-0.33

QoQ Revenue Growth

-100.0%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$173M

Total Liabilities

$17M

Stockholders' Equity

$155M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$5M	-100.0%
Gross Profit	-$10M	$5M	-281.5%
Operating Income	-$18M	-$16M	-17.5%
Net Income	-$16M	-$14M	-13.6%